Real|World Evidence of a Successful Biosimilar Adoption Program

Real-world evidence of a successful biosimilar adoption program

Biosimilars have introduced new opportunities to reduce the disproportionately high US healthcare spending on biologic medications.

Real-World Evidence of a Successful Biosimilar Adoption Program

This article describes strategic utilization management program initiatives designed to promote biosimilar utilization, reduce biologic drug costs and increase ...

Real-world evidence of a successful biosimilar adoption program.

Biosimilars have introduced new opportunities to reduce the disproportionately high US healthcare spending on biologic medications.

The Role of Real-World Evidence in the Adoption of Biosimilars - UBC

Study authors concluded that limited information on the safety, efficacy, and immunogenicity of biosimilars at the time of regulatory approval needs to be ...

Research and Studies | Leading Resource on Biosimilars

Real-World Evidence of a Successful Biosimilar Adoption Program ... This article describes how Providence St Joseph Health, a large US nonprofit health system, ...

Using Real-World Data to Better Understand Biosimilar Adoption ...

Having this information allows provider organizations to develop a strategy that can address unexpected findings like this, focusing on provider ...

The first 2 years of the program created $26.9 million in cost savings and “biosimilar adoption rates that greatly exceed the US national ...

Biosimilars have the potential to improve access to effective therapies by lowering costs, but their demand is regulated by physicians. Physicians express ...

CONCLUSIONS: Implementation of a biosimilar adoption program can be successful ... ▫ Having more real-world evidence in the US from biosimilar adoption experience ...

Real-World Evidence of Biosimilar Utilisation and ...

Despite the scarcity of evidence addressing the cost-effectiveness of biosimilars in breast and lung cancer treatment, biosimilars may offer a ...

Overcoming barriers to biosimilar adoption: real-world perspectives ...

The 2 strategies that received the highest likelihood rating among providers were educational programs for prescribers that (1) focus on evidence from studies ...

Real-World Evidence on Biosimilar Adherence and Adoption

Real-world evidence was considered an important way to overcome adoption barriers and 55% of respondents said they expect their organization's ...

Resource Library – Biosimilars Adoption | Breaking through Barriers

Real-world evidence of a successful biosimilar adoption program. Topics ... Overcoming barriers to biosimilar adoption: real-world perspectives from a national ...

Insights and Strategies With Dr Sophia Humphreys

... biosimilar adoption rates to improve uptake in slower markets? ... data on the success of their biosimilar programs. This real-world evidence ...

Sharing the real-world evidence value of oncology biosimilar adoption

This programme shares the latest data surrounding successful implementation of oncology biosimilars through an abstract library of key published paper ...

Real-World Uptake and Utilization Patterns of Biosimilars in Clinical ...

In addition, RWE studies can provide data that differentiate a single biosimilar from competitors by evaluating outcomes specific to the biosimilar product that ...

Successful biosimilar adoption in oncology: strategic approach to ...

Conclusions: This real-world data suggest use of an integrated electronic health record to standardize biosimilar utilization in oncology and ...

Successful increase of biosimilar adoption in a large integrated ...

In summary, the above-described programme increased the acceptance of biosimilars, decreased the biologicals spend, simplified HCP workflow and improved overall ...

Successful biosimilar adoption in oncology: strategic approach to ...

This prompted this comparative pharmacovigilance study using real-world clinical data. Consistent with the expected ... [Show full abstract] similarity in ...

A successful model of biosimilar adoption in a community oncology ...

Background: The emergence of biosimilars creates an opportunity for more cost-effective treatment. Utilization of biologics in cancer care ...